Portfolio Complexity-Cost Exposure Director

The mandate

The group’s catalogue has doubled while reported product margins remain acceptable, yet service expedites, small-batch changeovers, sterilisation queues, quality documentation and country-specific labels have grown faster than revenue. Prior SKU rationalisation ranked sales and gross margin but missed families whose apparent similarity creates different operating paths. The defined problem is to reveal decision-relevant complexity cost and protected customer value without pretending that accounting allocations identify causality.

The principal deliverable is a portfolio complexity-exposure model linking product and promise attributes to manufacturing paths, quality events, regulatory maintenance, inventory, order intervention, distribution handling and customer consequence. Supporting artefacts include an attribute dictionary, 25 pathway archetypes, avoidable-cost ranges, regulatory and contract constraints, a decision heat map and twelve worked portfolio choices. The scope diagnoses and frames choices; it does not execute discontinuations, reprice customers or redesign the cost ledger.

Milestone one, at week three, delivers reconciled catalogue, customer and pathway populations plus data limitations. Milestone two, at week seven, establishes archetypes and validates causal drivers through three site observations. Milestone three, at week twelve, supplies avoidable-cost and service-consequence ranges. Milestone four, at week sixteen, tests twelve retain, standardise, migrate or exit decisions. Milestone five, at month five, submits the accepted model, governance method and implementation backlog.

Acceptance requires Operations, Quality, Commercial and Finance to reproduce twelve cases from source transaction to pathway and explain which cost, capacity or risk changes if an option is taken. The model must distinguish allocated cost from avoidable resource, preserve protected regulatory and customer constraints, and reconcile populations to controlled systems within agreed tolerances. The portfolio council will sign when it can make the cases without external interpretation and owns a funded 100-day decision sequence.

The client will provide catalogue masters, bills and routings, batch histories, quality events, regulatory registrations, service promises, order interventions, inventory, freight, customer contribution and prior rationalisation work. It will nominate data owners and a six-person working group, secure plant and distribution access, and decide contested attribute definitions within four business days. Management retains product, customer, pricing, accounting, quality and discontinuation authority.

Why this is external work

Product leaders defend customer need, plants see disruption, Quality sees obligations and Finance sees allocated margin; none holds a neutral view of the complete pathway. The last internal exercise created a politically negotiated deletion list because its method could not survive case-level challenge. Independent operating analysis is needed before another portfolio action damages valuable service while leaving structural complexity untouched.

What you will own

• Reconcile catalogue, customer, plant, regulatory and service populations and publish every material inclusion, exclusion and data limitation.
• Define 25 operating-path archetypes from observable attributes rather than management labels or assumed product-family similarity.
• Quantify avoidable labour, capacity, inventory, quality, documentation, intervention and distribution exposure as defensible ranges.
• Separate value-creating variety from accidental variants, historic promises, duplicated registrations and low-volume bespoke operating paths.
• Work twelve portfolio cases through retain, standardise, migrate or exit choices with customer, regulatory and capacity consequences.
• Test model stability across sites, currencies, seasonal volumes and cost assumptions without converting uncertainty into spurious precision.
• Deliver the accepted exposure model, decision heat map, governance playbook, case files and sequenced 100-day backlog.

Candidate qualifications

• Diagnosed complexity economics in regulated manufacturing with thousands of variants, customer promises and multi-stage operating routes.
• Can distinguish allocated accounting cost, marginal transaction cost, constrained capacity and genuinely avoidable structural resource.
• Has linked master data, routings, quality events, registrations, service interventions and customer economics at case level.
• Led portfolio choices where simplistic SKU reduction would have removed valuable products while preserving difficult underlying pathways.
• Can explain causal ranges and limitations to operators, scientists, commercial leaders, controllers and executive committees.
• Delivered a model internal teams could reproduce and govern after external analysts left, including disputed case resolution.

Non-negotiables

• Can attend all three European site visits and lead bilingual executive sessions with local support where necessary.
• Will not bundle software, outsourcing, pricing execution or product-discontinuation services into the diagnostic.
• Accepts that product, customer, quality, accounting and exit decisions remain with authorised client leaders.
• Brings transaction-to-path complexity evidence; high-level portfolio benchmarking or gross-margin analysis alone is insufficient.

1. 49 words maximum. Describe a low-volume product whose removal failed to release the operating cost leaders expected.
2. 49 words maximum. How would you prove that a quality-documentation burden is caused by variant complexity?
3. 49 words maximum. Which three source populations would you reconcile before constructing pathway archetypes?